Publications

Structural analysis of the catalytic core of human telomerase RNA by FRET and molecular modeling.

Authors: G Gavory, MF Symmons, Y Krishnan Ghosh, D Klenerman, S Balasubramanian

Research group: Balasubramanian Group

E-pub date: 7 Nov 2006

Journal name: Biochemistry

Genome-wide analysis of estrogen receptor binding sites.

Authors: JS Carroll, CA Meyer, J Song, W Li, TR Geistlinger, J Eeckhoute, AS Brodsky...

Research group: Carroll Group

E-pub date: 1 Nov 2006

Journal name: Nat Genet

Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis.

Authors: SC Clifford, ME Lusher, JC Lindsey, JA Langdon, RJ Gilbertson, D Straughton...

Research group: Gilbertson Group

E-pub date: 1 Nov 2006

Journal name: Cell Cycle

Distinct catalytic and non-catalytic roles of ARGONAUTE4 in RNA-directed DNA methylation.

Authors: Y Qi, X He, X-J Wang, O Kohany, J Jurka, GJ Hannon

Research group: Hannon Group

E-pub date: 26 Oct 2006

Journal name: Nature

Oxazole-based peptide macrocycles: a new class of G-quadruplex binding ligands.

Authors: K Jantos, R Rodriguez, S Ladame, PS Shirude, S Balasubramanian

Research group: Balasubramanian Group

E-pub date: 25 Oct 2006

Journal name: J Am Chem Soc

Artefactual computed tomographic middle cerebral artery territory infarct.

Authors: M Crocker, M Murphy, K-A Price, D Stock, D McIntyre, B Chitnavis

Research group: Pre-clinical imaging

E-pub date: 1 Oct 2006

Journal name: Br J Neurosurg

Epirubicin, Cisplatin and Capecitabine [Ecx] for Relapsed Epithelial Ovarian Cancer: Results of a Pilot Study

Authors: HM Hatcher, M Iddawela, J Abraham, CA Palmer, C Parkinson, J Pratt, HM Earl

Research group: Brenton Group

E-pub date: 1 Oct 2006

Journal name: International Journal of Gynecological Cancer

A Randomised Phase ii Trial in Advanced Epithelial Ovarian Cancer (Eoc), With Prospective Translational End-Points to Predict Chemotherapy Response (Ctcr-Ov01)

Authors: AA Ahmed, A-L Vallier, C Parkinson, M Iddawela, J Latimer, R Crawford, JD B...

Research group: Brenton Group

E-pub date: 1 Oct 2006

Journal name: International Journal of Gynecological Cancer

Filters

Research Groups

Core Facilities

Start date

End date

Structural analysis of the catalytic core of human telomerase RNA by FRET and molecular modeling.

Genome-wide analysis of estrogen receptor binding sites.

Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis.

Distinct catalytic and non-catalytic roles of ARGONAUTE4 in RNA-directed DNA methylation.

Oxazole-based peptide macrocycles: a new class of G-quadruplex binding ligands.

Artefactual computed tomographic middle cerebral artery territory infarct.

Epirubicin, Cisplatin and Capecitabine [Ecx] for Relapsed Epithelial Ovarian Cancer: Results of a Pilot Study

A Randomised Phase ii Trial in Advanced Epithelial Ovarian Cancer (Eoc), With Prospective Translational End-Points to Predict Chemotherapy Response (Ctcr-Ov01)

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Structural analysis of the catalytic core of human telomerase RNA by FRET and molecular modeling.

Genome-wide analysis of estrogen receptor binding sites.

Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis.

Distinct catalytic and non-catalytic roles of ARGONAUTE4 in RNA-directed DNA methylation.

Oxazole-based peptide macrocycles: a new class of G-quadruplex binding ligands.

Artefactual computed tomographic middle cerebral artery territory infarct.

Epirubicin, Cisplatin and Capecitabine [Ecx] for Relapsed Epithelial Ovarian Cancer: Results of a Pilot Study

A Randomised Phase ii Trial in Advanced Epithelial Ovarian Cancer (Eoc), With Prospective Translational End-Points to Predict Chemotherapy Response (Ctcr-Ov01)